Real-life study for the diagnosis of house dust mite allergy - The value of recombinant allergen-based IgE serology

International Archives of Allergy and Immunology

Volumn 170, Issue 2, 2016, Pages 132-137

  Becker, Sven ^a,b   Schlederer, Thomas ^c   Kramer, Matthias F ^b   Haack, Mareike ^b   Vrtala, Susanne ^c   Resch, Yvonne ^c   Lupinek, Christian ^c   Valenta, Rudolf ^c   Gröger, Moritz ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Allergen components; Allergic rhinitis; Der p 1; Der p 2; Der p 23; Dermatophagoides pteronyssinus; House dust mites; Major allergens

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; PYROXYLIN; RECOMBINANT ALLERGEN; ALLERGEN; HOUSE DUST ALLERGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOCHIP; CHILD; DERMATOPHAGOIDES PTERONYSSINUS; ENZYME IMMUNOASSAY; FEMALE; HOUSE DUST ALLERGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR WEIGHT; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; RHINORRHEA; SENSITIZATION; SEROLOGY; SNEEZING; ANIMAL; BLOOD; HYPERSENSITIVITY; IMMUNOLOGY; MIDDLE AGED; PYROGLYPHIDAE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; CHILD; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; PYROGLYPHIDAE; SEROLOGIC TESTS; YOUNG ADULT;

EID: 84981549480     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000447694     Document Type: Article

References (27)

1. Bousquet J, Lockey R, Malling HJ, Alvarez-Cuesta E, Canonica GW, Chapman MD, et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American Academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998; 81: 401-405.
2. Pittner G, Vrtala S, Thomas WR, Weghofer M, Kundi M, Horak F, et al. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens. Clin Exp Allergy 2004; 34: 597-603.
3. Westritschnig K, Sibanda E, Thomas W, Auer H, Aspock H, Pittner G, et al. Analysis of the sensitization profile towards allergens in central Africa. Clin Exp Allergy 2003; 33: 22-27.
4. Becker S, Kramer MF, Havel M, Welz C, Markmann S, Groger M. IgE reactivity profiles among house dust mite allergic patients in Bavaria. Eur Arch Otorhinolaryngol 2013; 270: 3177-3182.
5. Weghofer M, Thomas WR, Kronqvist M, Mari A, Purohit A, Pauli G, et al. Variability of IgE reactivity profiles among European mite allergic patients. Eur J Clin Invest 2008; 38: 959-965.
6. Becker S, Groger M, Canis M, Pfrogner E, Kramer MF. Tropomyosin sensitization in house dust mite allergic patients. Eur Arch Otorhinolaryngol 2012; 269: 1291-1296.
7. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007; 1: CD001936.
8. Nelson HS. Update on house dust mite immunotherapy: are more studies needed?. Curr Opin Allergy Clin Immunol 2014; 14: 542-548.
9. Calderon MA, Casale TB, Nelson HS, Demoly P. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. J Allergy Clin Immunol 2013; 132: 1322-1336.
10. Meyer CH, Bond JF, Chen MS, Kasaian MT. Comparison of the levels of the major allergens Der p I and Der p II in standardized extracts of the house dust mite, Dermatophagoides pteronyssinus . Clin Exp Allergy 1994; 24: 1041-1048.
11. Weghofer M, Grote M, Resch Y, Casset A, Kneidinger M, Kopec J, et al. Identification of Der p 23, a peritrophin-like protein, as a new major Dermatophagoides pteronyssinus allergen associated with the peritrophic matrix of mite fecal pellets. J Immunol 2013; 190: 3059-3067.
12. Lupinek C, Wollmann E, Baar A, Banerjee S, Breiteneder H, Broecker BM, et al. Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip. Methods 2014; 66: 106-119.
13. Riechelmann H, Bachert C, Goldschmidt O, Hauswald B, Klimek L, Schlenter WW, et al. Application of the nasal provocation test on diseases of the upper airways. Position paper of the German Society for Allergology and Clinical Immunology (ENT Section) in cooperation with the Working Team for Clinical Immunology (in German). Laryngorhinootologie 2003; 82: 183-188.
14. Bronnert M, Mancini J, Birnbaum J, Agabriel C, Liabeuf V, Porri F, et al. Component-resolved diagnosis with commercially available D. pteronyssinus der p 1, der p 2, and der p 10: relevant markers for house dust mite allergy. Clin Exp Allergy 2012; 42: 1406-1415.
15. Thomas WR, Smith WA, Hales BJ, Mills KL, O?Brien RM. Characterization and immunobiology of house dust mite allergens. Int Arch Allergy Immunol 2002; 129: 1-18.
16. Thomas WR, Smith WA, Hales BJ. The allergenic specificities of the house dust mite. Chang Gung Med J 2004; 27: 563-569.
17. Trombone AP, Tobias KR, Ferriani VP, Schuurman J, Aalberse RC, Smith AM, et al. Use of a chimeric ELISA to investigate immunoglobulin E antibody responses to Der p 1 and Der p 2 in mite-Allergic patients with asthma, wheezing and/or rhinitis. Clin Exp Allergy 2002; 32: 1323-1328.
18. Soh WT, Le Mignon M, Suratannon N, Satitsuksanoa P, Chatchatee P, Wongpiyaboron J, et al. The house dust mite major allergen Der p 23 displays O -glycan-independent IgE reactivities but no chitin-binding activity. Int Arch Allergy Immunol 2016; 168: 150-160.
19. Hales BJ, Laing IA, Pearce LJ, Hazell LA, Mills KL, Chua KY et al: Distinctive immunoglobulin E anti-house dust allergen-binding specificities in a tropical Australian Aboriginal community Clin Exp Allergy 2007 37 1357-1363.
20. Yasueda H, Mita H, Yui Y, Shida T. Comparative analysis of physicochemical and immunochemical properties of the two major allergens from Dermatophagoides pteronyssinus and the corresponding allergens from Dermatophagoides farinae . Int Arch Allergy Appl Immunol 1989; 88: 402-407.
21. Chan TF, Ji KM, Yim AK, Liu XY, Zhou JW, Li RQ, et al. The draft genome, transcriptome, and microbiome of Dermatophagoides farinae reveal a broad spectrum of dust mite allergens. J Allergy Clin Immunol 2015; 135: 539-548.
22. Malandain H. IgE-reactive carbohydrate epitopes-classification, cross-reactivity, and clinical impact (2nd part). Eur Ann Allergy Clin Immunol 2005; 37: 247-256.
23. van Ree R. Carbohydrate epitopes and their relevance for the diagnosis and treatment of allergic diseases. Int Arch Allergy Immunol 2002; 129: 189-197.
24. Altmann F. The role of protein glycosylation in allergy. Int Arch Allergy Immunol 2007; 142: 99-115.
25. Vidal C, Sanmartin C, Armisen M, Rodriguez V, Linneberg A, Gonzalez-Quintela A. Minor interference of cross-reactive carbohydrates with the diagnosis of respiratory allergy in standard clinical conditions. Int Arch Allergy Immunol 2012; 157: 176-185.
26. Malandain H, Giroux F, Cano Y. The influence of carbohydrate structures present in common allergen sources on specific IgE results. Eur Ann Allergy Clin Immunol 2007; 39: 216-220.
27. Casset A, Mari A, Purohit A, Resch Y, Weghofer M, Ferrara R, et al. Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts. Int Arch Allergy Immunol 2012; 159: 253-262.